Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul-Aug;41(4):471-473.
doi: 10.1016/j.nefro.2020.08.003. Epub 2020 Oct 8.

A patient with COVID-19 and anti-glomerular basement membrane disease

Affiliations

A patient with COVID-19 and anti-glomerular basement membrane disease

Neriman Sila Koc et al. Nefrologia. 2021 Jul-Aug.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Glomerulus with focal fibrinoid necrosis (A, hematoxylin-eosin), another glomerulus with fibrinoid necrosis, which can be seen as the pink argyrophobic area in the silver stain (B, Jones methenamine silver). Glomerulus with partial cellular crescent formation (C, hematoxylin–eosin stain), another glomerulus with extensive extracapillary proliferation filling the Bowman space and part of a tubule filled with a red blood cell cast (D, hematoxylin–eosin stain). Accompanying interstitial inflammation with abundance of eosinophils (E, hematoxylin–eosin stain). Immunofluorescence microscopy showing lineer IgG along the glomerular basement membrane (F).
Fig. 2
Fig. 2
Chest computerized tomography revealed anti-GBM disease but could not exclude accompanying infection.

References

    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Marques C., Plaisier E., Cacoub P., Cadranel J., Saadoun D. Review on anti-glomerular basement membrane disease or Goodpasture's syndrome. Rev Med Intern. 2019;41:14–20. doi: 10.1016/j.revmed.2019.10.338. - DOI - PubMed
    1. Memoli M.J., Athota R., Reed S., Czajkowski L., Bristol T., Proudfoot K. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2014;58:214–224. doi: 10.1093/cid/cit725. - DOI - PMC - PubMed
    1. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020 doi: 10.1002/lt.25756. - DOI - PubMed
    1. Monti S., Balduzzi S., Delvino P., Bellis E., Quadrelli V.S., Montecucco C. Clinical course of Covıd-19 in a series of patients with chronic arthritis treated with ımmunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667–668. doi: 10.1136/annrheumdis-2020-217424. - DOI - PMC - PubMed